Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Chang

Showing results (311-320 of 329) with videos related to

Pageof 33
Sort By:
The Journal of Urology|December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
Free Neuropathology|June 13, 2025
Applying machine learning to assist in the morphometric assessment of brain arteriolosclerosis through automationJerry J Lou, Peter Chang, Kiana D Nava, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without AbirateroneRana R McKay, Huihui Ye, Wanling Xie, et al.
Cancer|January 1, 2024
Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trialRana R McKay, Wanling Xie, Xiaoyu Yang, et al.
The Journal of Allergy and Clinical Immunology|April 7, 2022
Lirentelimab for severe and chronic forms of allergic conjunctivitisStephen D Anesi, Joseph Tauber, Quan Dong Nguyen, et al.
JCO Precision Oncology|September 19, 2019
Low Abundance of Circulating Tumor DNA in Localized Prostate CancerS Thomas Hennigan, Shana Y Trostel, Nicholas T Terrigino, et al.
The Journal of Urology|September 6, 2016
Relief of Urinary Symptom Burden after Primary Prostate Cancer TreatmentPeter Chang, Meredith M Regan, Montserrat Ferrer, et al.
Carcinogenesis|September 16, 2006
An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humansStefano Bonassi, Ariana Znaor, Marcello Ceppi, et al.
Health Literacy Research and Practice|July 12, 2019
Health Literacy and PowerMichael K Paasche-Orlow, Dean Schillinger, Barry D Weiss, et al.
The Oncologist|June 4, 2026
Multidisciplinary Clinics in Cancer-Models, Metrics, and Meaning: A ReviewSeohyuk Lee, Jim W Doolin, David E Avigan, et al.
Pageof 33

Showing results (311-320 of 329) with videos related to

Sort By:
Pageof 33
The Journal of Urology|December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
Free Neuropathology|June 13, 2025
Applying machine learning to assist in the morphometric assessment of brain arteriolosclerosis through automationJerry J Lou, Peter Chang, Kiana D Nava, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without AbirateroneRana R McKay, Huihui Ye, Wanling Xie, et al.
Cancer|January 1, 2024
Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trialRana R McKay, Wanling Xie, Xiaoyu Yang, et al.
The Journal of Allergy and Clinical Immunology|April 7, 2022
Lirentelimab for severe and chronic forms of allergic conjunctivitisStephen D Anesi, Joseph Tauber, Quan Dong Nguyen, et al.
JCO Precision Oncology|September 19, 2019
Low Abundance of Circulating Tumor DNA in Localized Prostate CancerS Thomas Hennigan, Shana Y Trostel, Nicholas T Terrigino, et al.
The Journal of Urology|September 6, 2016
Relief of Urinary Symptom Burden after Primary Prostate Cancer TreatmentPeter Chang, Meredith M Regan, Montserrat Ferrer, et al.
Carcinogenesis|September 16, 2006
An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humansStefano Bonassi, Ariana Znaor, Marcello Ceppi, et al.
Health Literacy Research and Practice|July 12, 2019
Health Literacy and PowerMichael K Paasche-Orlow, Dean Schillinger, Barry D Weiss, et al.
The Oncologist|June 4, 2026
Multidisciplinary Clinics in Cancer-Models, Metrics, and Meaning: A ReviewSeohyuk Lee, Jim W Doolin, David E Avigan, et al.
Pageof 33